Skip to main content
Clinical Trials/NCT05760885
NCT05760885
Recruiting
Early Phase 1

Multisensory Augmentation to Improve the Standing Balance of People With Chronic Stroke

VA Office of Research and Development2 sites in 1 country36 target enrollmentJanuary 14, 2025

Overview

Phase
Early Phase 1
Intervention
Balance training with sensory augmentation
Conditions
Stroke
Sponsor
VA Office of Research and Development
Enrollment
36
Locations
2
Primary Endpoint
Berg Balance Scale score change
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

Many individuals who experience a stroke have problems with their balance. In part, these balance problems may be due to sensory issues. This study will test whether sensory augmentation has the potential to improve post-stroke balance. Sensory augmentation is a method by which non-invasive vibration is used to enhance the sensory information available to users, which may make it easier to feel where they are and prevent losses of balance.

Detailed Description

The objective of this study is to design a novel multisensory augmentation approach to improve the control of standing balance in people with chronic stroke. With sensory augmentation, artificial feedback provides the nervous system with information about the dynamic state of the body, which can be used to prevent losses of balance. This clinical trial will investigate whether multisensory augmentation produces sustained balance improvements when applied as a training device. These potential improvements will be assessed by comparing the results of clinical and biomechanical assessments before and after a 10-week balance training program, in which half of the participants will be randomly assigned sensory augmentation.

Registry
clinicaltrials.gov
Start Date
January 14, 2025
End Date
January 1, 2027
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age of at least 21 years;
  • Experience of a stroke at least 6 months prior to participation;
  • Berg Balance Scale score less than 52
  • Ability to stand independently for at least 1 minute without wearing an AFO or other brace that would preclude delivery of stimulation to the ankle or foot sole
  • Provision of informed consent

Exclusion Criteria

  • Resting blood pressure higher than 220/110 mm Hg
  • History of unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living
  • Pre-existing neurological disorders or dementia
  • Severe visual impairment
  • History of DVT or pulmonary embolism within 6 months
  • Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions

Arms & Interventions

Sensory Augmentation

Participants will receive sensory augmentation in the form of non-invasive vibration, while balance training is performed as described below.

Intervention: Balance training with sensory augmentation

Control

Participants will receive balance training, without any sensory augmentation.

Intervention: Balance training

Outcomes

Primary Outcomes

Berg Balance Scale score change

Time Frame: Before and after a 10-week period of balance training

A standard clinical assessment to measure balance performance during various functional tasks

Secondary Outcomes

  • Limits of Stability score (paretic direction)(Before and after a 10-week period of balance training)
  • Limits of Stability score (non-paretic direction)(Before and after a 10-week period of balance training)
  • Mediolateral center of pressure displacement(Before and after a 10-week period of balance training)
  • Mediolateral center of pressure velocity(Before and after a 10-week period of balance training)

Study Sites (2)

Loading locations...

Similar Trials